AnticoagEvaluator

30.2K installs
68 ratings
326 monthly active users
Revenue not available
Install Trends
Weekly +27
Steady
Monthly +389
Steady

AnticoagEvaluator Summary

AnticoagEvaluator is a mobile Android app in Medical by American College of Cardiology Foundation. Released in Dec 2015 (10 years ago). It has about 30.2K+ installs and 68 ratings with a 4.80★ (excellent) average. Based on AppGoblin estimates, it reaches roughly 326 monthly active users . Store metadata: updated Nov 21, 2024.

Recent activity: 27 installs this week (389 over 4 weeks) showing steady growth View trends →

Store info: Last updated on Google Play on Nov 21, 2024 .


4.8★

Ratings: 68

5★
4★
3★
2★
1★

Screenshots

App screenshot
App screenshot
App screenshot
App screenshot

App Description

Make informed anti thrombotic therapy decisions for AF patients.

Make well-informed decisions on anti thrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for anti thrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com